Company: TVRD
Filing Date: 2025-01-17
Form Type: 425
Source: 0001104659-25-004519
Chunk: 0

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-17
Form: 425
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
January 14, 2025

CARA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)</div>

| Delaware                                                           |     | 001-36279   |     |         75-3175693 |
| (State or other jurisdiction                                       
 of incorporation)                                                  |     | -Commission 
 File Number |     |      -IRS Employer 
 Identification No. |
| 400 Atlantic Street                                                
 Suite 500                                                          
 Stamford, Connecticut                                              |     |             |     |              06901 |
| (Address of principal executive offices)                           |     |             |     |          -Zip Code |
| Registrant's telephone number, including area code: (203) 406-3700 |     |             |     |                    |

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2.):

| x | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |

| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |

| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |

| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title                                    
 of each class                            | Trading   
 Symbol(s) | Name                        
 of each exchange on which   
 registered                  |
| Common Stock, par value $0.001 per share | CARA      | The Nasdaq Stock Market LLC |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (